These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 20512988)

  • 1. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.
    Syn WK; Oo YH; Pereira TA; Karaca GF; Jung Y; Omenetti A; Witek RP; Choi SS; Guy CD; Fearing CM; Teaberry V; Pereira FE; Adams DH; Diehl AM
    Hepatology; 2010 Jun; 51(6):1998-2007. PubMed ID: 20512988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.
    Syn WK; Agboola KM; Swiderska M; Michelotti GA; Liaskou E; Pang H; Xie G; Philips G; Chan IS; Karaca GF; Pereira Tde A; Chen Y; Mi Z; Kuo PC; Choi SS; Guy CD; Abdelmalek MF; Diehl AM
    Gut; 2012 Sep; 61(9):1323-9. PubMed ID: 22427237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.
    Syn WK; Choi SS; Liaskou E; Karaca GF; Agboola KM; Oo YH; Mi Z; Pereira TA; Zdanowicz M; Malladi P; Chen Y; Moylan C; Jung Y; Bhattacharya SD; Teaberry V; Omenetti A; Abdelmalek MF; Guy CD; Adams DH; Kuo PC; Michelotti GA; Whitington PF; Diehl AM
    Hepatology; 2011 Jan; 53(1):106-15. PubMed ID: 20967826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice.
    Zheng S; Yang W; Yao D; Tang S; Hou J; Chang X
    Ann Med; 2022 Dec; 54(1):2233-2245. PubMed ID: 35950602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
    Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
    Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
    Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease.
    Syn WK; Jung Y; Omenetti A; Abdelmalek M; Guy CD; Yang L; Wang J; Witek RP; Fearing CM; Pereira TA; Teaberry V; Choi SS; Conde-Vancells J; Karaca GF; Diehl AM
    Gastroenterology; 2009 Oct; 137(4):1478-1488.e8. PubMed ID: 19577569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH.
    Sutti S; Jindal A; Locatelli I; Vacchiano M; Gigliotti L; Bozzola C; Albano E
    Hepatology; 2014 Mar; 59(3):886-97. PubMed ID: 24115128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
    Velayudham A; Dolganiuc A; Ellis M; Petrasek J; Kodys K; Mandrekar P; Szabo G
    Hepatology; 2009 Mar; 49(3):989-97. PubMed ID: 19115316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis.
    Kremer M; Thomas E; Milton RJ; Perry AW; van Rooijen N; Wheeler MD; Zacks S; Fried M; Rippe RA; Hines IN
    Hepatology; 2010 Jan; 51(1):130-41. PubMed ID: 20034047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis.
    Li Z; Oben JA; Yang S; Lin H; Stafford EA; Soloski MJ; Thomas SA; Diehl AM
    Hepatology; 2004 Aug; 40(2):434-41. PubMed ID: 15368448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production.
    Omenetti A; Syn WK; Jung Y; Francis H; Porrello A; Witek RP; Choi SS; Yang L; Mayo MJ; Gershwin ME; Alpini G; Diehl AM
    Hepatology; 2009 Aug; 50(2):518-27. PubMed ID: 19575365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
    Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
    Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis.
    Maricic I; Marrero I; Eguchi A; Nakamura R; Johnson CD; Dasgupta S; Hernandez CD; Nguyen PS; Swafford AD; Knight R; Feldstein AE; Loomba R; Kumar V
    J Immunol; 2018 Nov; 201(10):3017-3035. PubMed ID: 30322964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.
    Heinrichs D; Brandt EF; Fischer P; Köhncke J; Wirtz TH; Guldiken N; Djudjaj S; Boor P; Kroy D; Weiskirchen R; Bucala R; Wasmuth HE; Strnad P; Trautwein C; Bernhagen J; Berres ML
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
    Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
    J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.